Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.
The Agency for the Management of University and Research Grants (AGAUR) has awarded the grant for the funding of research projects PANDÈMIES 2020 to the MiL@b research group of the IISPV, the URV and the spin-off Biosfer Teslab, SL. The call granted has been “Replegar-se per crèixer: l’impacte de les pandèmies en un món sense […]
Biosfer Teslab Collaborates in Cancer Studies
Metabolomics can help in the study of different cancers by analysing whether a particular type of tumour is characterised by the development of certain metabolites. To this aim, Biosfer Teslab collaborates directly with Josep Gumà, director of the Oncology Institute of Southern Catalonia, and together with the Higher Technical School of Engineering of the URV […]
Early molecular signature of Parkinson and dementia years before the diseases appear
NMR metabolomics could identify altered lipoprotein and protein glycosylation profiles in REM sleep behavior disorder (iRBD), the prodromal stage of Lewy-type synucleinopathies (LTS) -including Parkinson and dementia. NMR showed predictive power distinguishing future clinical outcome, being a useful tool for identifying short-term high-risk patients for conversion to parkinsonism or dementia. Here you can see the […]
